Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by zwerp2000on Jan 23, 2023 7:06pm
249 Views
Post# 35241052

This is why i love this board

This is why i love this board There is a such a disconnect between fantasy and reality, 

First is the fantasy. BTI has a billion dollar+ platform that has yet to be recognized and either most of the biotech world can't see that and/or management is stealing it away from shareholders

Then there is the reality. The stock is trading at $.02. The company has no money. The company for many years has not been able to raise any significant monies. The company has no drugs in the clinic. The company has failed to come through on any of its plans. One company after another has evaluated the technology and has passed on it. The company has been around for years and has accomplished pretty much nothing. But yeah, they have an incredible platform worth billions. A tiny canadian biotech company that can't sell itself for pretty much nothingg as seen today is at the forefront of the BBB. Yeah, sure. 

It's just too funny what some of you actually believe. Bankruptcy is coming. 


<< Previous
Bullboard Posts
Next >>